- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01502449
Delivery of Self Training and Education for Stressful Situations-Telephone Version (DESTRESS-T)
January 11, 2012 updated by: Charles Engel, Uniformed Services University of the Health Sciences
Randomized Trial of Telephonic Psychotherapy and Case Management for Combat-Related Posttraumatic Stress Disorder
This study will evaluate a telephone-delivered cognitive-behavioral psychotherapy intervention designed for primary care treatment of combat-exposed service members with PTSD.
The investigators will assess Posttraumatic Stress Disorder (PTSD) symptoms, mental health-related and occupational functioning, and symptoms of depression, anxiety, and somatization.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
This is a randomized controlled trial that will compare DESTRESS-T to Optimized Usual Care (OUC).
Optimized Usual Care is usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider (PCP), and care coordination.
Study Type
Interventional
Enrollment (Anticipated)
91
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Elizabeth Harper Cordova, MA
- Phone Number: 301-295-7339
- Email: elizabeth.harper1@us.army.mil
Study Contact Backup
- Name: Kristie Gore, Ph.D.
- Phone Number: 301-295-7351
- Email: kristie.gore@us.army.mil
Study Locations
-
-
Georgia
-
Columbus, Georgia, United States, 31905
- Fort Benning - Martin Army Community Hospital
-
Contact:
- Elizabeth Harper Cordova, MA
- Phone Number: 301-295-7339
- Email: elizabeth.harper1@us.army.mil
-
Contact:
- Kristie L. Gore, Ph.D.
- Phone Number: 301-295-7351
- Email: kristie.gore@us.army.mil
-
Principal Investigator:
- Sharon A. Maxwell, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age>18 years
- DSM-IV diagnosis of PTSD (derived from the CAPS) due to combat in OIF/OEF deployment
- Active duty personnel
Exclusion Criteria:
- Active suicidal or violent ideation within the past two months as assessed by the MINI and a supplementary form developed by the project team (see Appendices)
- Current participation in any active psychotherapy (e.g., psychoanalysis, CBT) for mood, anxiety or substance use disorders (as determined via service member self report and/or check of medical record)
- Recurrent PTSD treatment failure in psychotherapy, as determined via consensus of study team members (Dr. Charles Engel, Dr. Brett Litz, and Dr. Kristie Gore)
- Current alcohol dependence, as assessed by MINI
- Acute psychosis, psychotic episode, or psychotic disorder diagnosis within the past year, as assessed by the MINI
- Currently on an antipsychotic or mood-stabilizing agent for bipolar disorder or any disorder with psychotic features, as determined by medical record and/or self report
- Unstable administration schedule or dosing of any antidepressant, anxiolytic, or sedative-hypnotic (i.e., will exclude for any related medication changes in the month prior to randomization), as determined by medical record or service member self report
- Acute or unstable physical illness based on the judgment of the patient's primary care clinician and the study team.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: DESTRESS-T
Usual primary care PTSD treatment, plus a telephone care management program over 8 weeks that includes: four outreach calls, feedback to the treating primary care provider, and care coordination
|
Usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider, and care coordination
Other Names:
|
Active Comparator: Optimized Usual Care (OUC)
Optimized Usual Care is usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider (PCP), and care coordination.
|
Optimized Usual Care is usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider (PCP), and care coordination.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Posttraumatic Stress Disorder Checklist - Civilian Version (PCL)
Time Frame: Baseline, 12 weeks, 18 weeks, and 24 weeks
|
Symptoms of PTSD will be assessed using the PTSD Checklist-Civilian Version.
The PCL is a self-report measure developed for measuring PTSD symptom severity and for estimating PTSD caseness when administration of a structured clinical interview is not feasible.
Respondents rate PCL items on a 5-point scale ("not at all" through "extremely") to indicate the degree to which they have been bothered by each of 17 PTSD symptoms during the past month.
Possible PCL scores range from 17 to 85.
|
Baseline, 12 weeks, 18 weeks, and 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Medical Outcomes Survey Short-Form-12 (SF-12)
Time Frame: Baseline, 12 weeks, 18 weeks, and 24 weeks
|
The SF-12 is a commonly used measure of mental and physical functional status.
The 12 items in the SF-12 are a subset of those in the SF-36.
The SF-12 contains one or two items from each of the eight health scales: physical functioning, role limitations due to physical health problems, bodily pain, general health, vitality (energy/fatigue), social functioning, and role limitations due to emotional problems and mental health (psychological distress and psychological well being).
The SF-12 will allow us to characterize the functional status of our sample.
|
Baseline, 12 weeks, 18 weeks, and 24 weeks
|
World Health Organization Health & Work Performance Questionnaire (HPQ)
Time Frame: Baseline, 12 weeks, 18 weeks, and 24 weeks
|
We will use the 21-item 7-day clinical trial version of the World Health Organization Health & Work Performance Questionnaire (HPQ) to measure the impact of DESTRESS-PC on occupational functioning.
The HPQ is a self-report questionnaire that obtains information about three types of workplace consequences: absenteeism (missed work days due to illness), presenteeism (low performance at work), and critical incidents.
|
Baseline, 12 weeks, 18 weeks, and 24 weeks
|
Patient Health Questionnaire (PHQ)
Time Frame: Baseline, 12 weeks, 18 weeks, and 24 weeks
|
The PHQ is a self-report assessment of common mental disorders developed specifically for primary care.
PHQ allows brief provisional primary care diagnoses of a several disorders including major depression, panic disorder, other anxiety disorder, and multisomatoform disorder.
We will use the PHQ for brief assessments of depression, anxiety (panic and generalized anxiety), and somatic symptom severity, assessments with excellent correspondence to DSM-IV diagnostic criteria.
|
Baseline, 12 weeks, 18 weeks, and 24 weeks
|
Generalized Anxiety Symptom Severity (GAD-7)
Time Frame: Baseline
|
Generalized anxiety symptoms will be assessed using the GAD-7, a brief measure designed for use in general health settings.
|
Baseline
|
Sheehan Disability Scale (SDS)
Time Frame: baseline, 12 week, 18 week and 24 week
|
The SDS is a three-item self-reporting tool measuring the impairment of a disability on work, social life and family life/home responsibilities.
SDS is scored on a 10-point scale with 0 being "not at all disrupted" and being 10 "extremely disrupted" with any item scoring above 5 indicating a significant functional impairment in that domain.
It has been used as an outcome measure in studies of PTSD due to its construct criterion related validity.
|
baseline, 12 week, 18 week and 24 week
|
Alcohol Use Disorders Identification Test-Civilian version (AUDIT-C)
Time Frame: baseline, 12 week, 18 week, and 24 week
|
Audit-C is a brief screen that has been found to effectively discriminate between patients with a history of drinking problems and those without such a history, including hazardous drinking.
Its brevity ensures that clinicians will remember it, and administration time is minimal.
A positive total score is an indication for further screening and assessment
|
baseline, 12 week, 18 week, and 24 week
|
Numeric Rating Scale for Pain (NRS).
Time Frame: baseline, 12 week, 18 week, and 24 week
|
The NRS directs participants to rate pain intensity using three, 11-point, 0 ("no pain") to 10 ("pain as bad as you can imagine") numeric rating scales.
Instructions ask participants to "Please rate your pain by indicating the number that best describes your pain on average in the last 24 hours", pain "at its worst", and "pain at its least".
The NRS will be used in this study to evaluate the effect of acupuncture on comorbid symptoms of pain.
|
baseline, 12 week, 18 week, and 24 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: COL Charles C. Engel, MD, MPH, Uniformed Services University of the Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Anticipated)
January 1, 2014
Study Completion (Anticipated)
January 1, 2014
Study Registration Dates
First Submitted
December 12, 2011
First Submitted That Met QC Criteria
December 29, 2011
First Posted (Estimate)
December 30, 2011
Study Record Updates
Last Update Posted (Estimate)
January 12, 2012
Last Update Submitted That Met QC Criteria
January 11, 2012
Last Verified
January 1, 2012
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- D10-I-AR-J5-786
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
Imperial College Healthcare NHS TrustImperial College LondonRecruiting
-
VA Office of Research and DevelopmentUniversity of California, San DiegoRecruiting
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Active, not recruiting
-
Oregon Health and Science UniversityEnrolling by invitation
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentPortland VA Medical CenterActive, not recruiting
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare SystemCompleted
-
Creighton UniversityCompleted
-
VA Eastern KansasTerminated
Clinical Trials on DESTRESS-T
-
Duke UniversityCompletedStress ReductionUnited States
-
VA Office of Research and DevelopmentCompleted
-
Duke UniversityCompletedStress ReductionUnited States
-
Henry M. Jackson Foundation for the Advancement...National Institute of Mental Health (NIMH); United States Department of DefenseCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Biotronik SE & Co. KGCompletedHeart Failure | BradycardiaDenmark, Hong Kong, Austria, Germany, Belgium
-
University of California, BerkeleyUniversity of Nevada, Reno; World Bank; L'Office National de Nutrition, MadagascarRecruitingEarly Childhood DevelopmentMadagascar
-
Biotronik SE & Co. KGCompletedVentricular Fibrillation | Ventricular TachycardiaGermany, Czech Republic
-
University of South FloridaNational Cancer Institute (NCI)RecruitingCancer | Obesity, Childhood | SurvivorshipUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.RecruitingLymphoma | Multiple Myeloma | Acute Lymphoblastic LeukemiaChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina